| Schedule of Related Parties Transactions |
Amounts due from related parties consisted of the following as of December 31, 2025 and 2024:
|
|
|
December 31, 2025
|
|
December 31, 2024
|
|
Current
|
|
|
|
|
|
|
|
|
|
Libra Sciences Limited (Note b)
|
|
|
522,192 |
|
|
|
522,192 |
|
|
Allowance for credit loss
|
|
|
(522,192 |
)
|
|
|
(522,192 |
)
|
|
Total
|
|
$
|
|
|
|
$
|
|
|
Amounts due to related parties consisted of the following as of December 31, 2025 and 2024:
|
|
|
|
December 31, 2025
|
|
|
December 31, 2024
|
|
Current
|
|
|
|
|
|
|
|
Aeneas Group Limited (Note a)
|
|
$
|
79,180 |
|
$
|
79,180 |
|
Ian Huen
|
|
|
|
|
|
464 |
| |
|
$
|
79,180 |
|
$
|
79,644 |
|
Convertible notes to a related party
|
|
|
|
|
|
|
|
Jurchen Investment Corporation (Note 15)
|
|
|
3,418,500 |
|
|
3,238,500 |
|
Total
|
|
$
|
3,418,500 |
|
$
|
3,238,500 |
|
|
|
Year ended December 31, 2025
|
|
Year ended December 31, 2024
|
|
Year ended December 31, 2023
|
|
Loan from related parties (Note a)
|
|
|
|
|
|
|
|
|
|
|
|
– Aeneas Group Limited
|
|
$
|
|
|
$
|
|
|
$
|
2,500,000 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
Issuance of Convertible Note to related parties (Note 15)
|
|
|
|
|
|
|
|
|
|
|
|
– Jurchen Investment Corporation
|
|
$
|
|
|
$
|
|
|
$
|
3,000,000 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
Settlement of loan from a related party through issuance of Convertible Note (Note 15)
|
|
|
|
|
|
|
|
|
|
|
|
– Aeneas Group Limited
|
|
$
|
|
|
$
|
|
|
$
|
3,000,000 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
Interest expenses (Note a and Note 15)
|
|
|
|
|
|
|
|
|
|
|
|
– Aeneas Group Limited
|
|
$
|
|
|
$
|
|
|
$
|
71,123 |
|
|
– Jurchen Investment Corporation
|
|
$
|
180,000 |
|
$
|
180,000 |
|
$
|
58,500 |
|
|
– Aenco Technologies Ltd
|
|
$
|
|
|
$
|
|
|
$
|
(13,234 |
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
Loan to related parties (Note b)
|
|
|
|
|
|
|
|
|
|
|
|
– Libra Sciences Limited
|
|
$
|
|
|
$
|
|
|
$
|
92,459 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
Loan repayment and interest received from a related party (Note b)
|
|
|
|
|
|
|
|
|
|
|
|
– Talem Medical Group Limited
|
|
$
|
|
|
$
|
|
|
$
|
611,641 |
|
|
|
|
Year ended December 31, 2025
|
|
Year ended December 31, 2024
|
|
Year ended December 31, 2023
|
|
Interest income (Note b)
|
|
|
|
|
|
|
|
|
|
|
– Talem Medical Group Limited
|
|
$
|
|
|
$
|
|
|
$
|
4,637 |
|
– Libra Sciences Limited
|
|
$
|
|
|
$
|
|
|
$
|
8,963 |
| |
|
|
|
|
|
|
|
|
|
|
Consultant, secondment, management and administrative services fees (Note c)
|
|
|
|
|
|
|
|
|
|
|
– CGY Investments Limited
|
|
$
|
|
|
$
|
|
|
$
|
153,640 |
|
– ACC Medical Limited
|
|
$
|
|
|
$
|
|
|
$
|
138,768 |
| |
|
|
|
|
|
|
|
|
|
|
Administrative management services (Note d)
|
|
|
|
|
|
|
|
|
|
|
– Libra Sciences Limited
|
|
$
|
|
|
$
|
|
|
$
|
9,615 |
| |
|
|
|
|
|
|
|
|
|
|
Healthcare services income
|
|
|
|
|
|
|
|
|
|
|
– Aeneas Management Limited
|
|
$
|
|
|
$
|
|
|
$
|
961 |
|